Dequalinium(TM) vesicles form stable complexes with plasmid DNA which are protected from DNase attack

Biological Chemistry

Volumn 380, Issue 6, 1999, Pages 647-652

  Lasch, Jürgen ^a   Meye, Axel ^a   Taubert, Helge ^a   Koelsch, Regine ^a   Mansa Ard, Jasadee ^a   Weissig, Volkmar ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Antineoplastic DNA vehicle; Bolaamphiphile; Dequalinium; DNA; DNase attack protection; DQA complexes; DQAsomal gene transfer

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; DEOXYRIBONUCLEASE; DEQUALINIUM; FLUORESCEIN; LIPID; OLIGODEOXYNUCLEOTIDE; PLASMID DNA; DNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DENSITY GRADIENT CENTRIFUGATION; DNA DRUG COMPLEX; FLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL; ULTRASOUND; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; ELECTRON MICROSCOPY; FREEZE FRACTURE; HUMAN; METABOLISM; PARTICLE SIZE; PLASMID;

ANIMALIA;

CELL SURVIVAL; DEOXYRIBONUCLEASES; DEQUALINIUM; DNA; FREEZE FRACTURING; HUMANS; MICROSCOPY, ELECTRON; PARTICLE SIZE; PLASMIDS; TUMOR CELLS, CULTURED;

EID: 0032586976     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.080     Document Type: Article

References (13)

1. Bodden, W.L., Palayoor, S.T., and Hait, W.N. (1986). Selective antimitochondrial agents inhibit calmodulin. Biochem. Biophys. Res. Comm. 135 (2), 574-582.
2. + channels in hepatocytes and of nicotinic responses in skeletal muscle. Eur. J. Pharmacol. 236, 201-207.
3. Christman, J.E., Miller, D.S., Coward, P., Smith, L.H., and Teng, N.N. (1990). Study of selective cytotoxic properties of cationic, lipophilic mitochondrial-specific compounds in gynecologic malignancies. Gynecol. Oncol. 39, 72-79.
4. Furukawa, T., Kubota, T., Suto, A., Takahara, T., Yamaguchi, H., Takeuchi, T., Kase, S., Kodaira, S., Ishibiki, K., and Kitajima, M. (1991). Clinical usefulness of chemosensitivity testing using the MTT assay. J. Surg. Oncol. 48, 188-193.
5. Helige, C., Smolle, J.H., Zellnig, G., Fink-Puches, R., Kerl, H., and Tritthart, H.A. (1992). Effect of dequalinium on K1735-M2 melanoma cell growth, directional migration and invasion in vitro. Eur. J. Cancer 29A, 124-128.
6. Leatherbarrow, R.J. (1992). GraFit User's Guide, Version 3.0, Erithacus Software Ltd, Staines, U.K.
7. Moriyama, Y., Patel, V., and Futai, M. (1995). Quinacrine mustard and lipophilic cations inhibitory to both vacuolar (H(+)-ATPase and FOFI-ATP synthase. FEBS-Lett. 6, 69-72.
8. New, R.R.C. (1989). In: Liposomes a Practical Approach, R.R.C. New, ed. (Oxford, New York, Tokyo: IRL Press), p. 95-96.
9. Rotenberg, S.A., Smiley, S., Ueffing, M., Krauss, R.S., Chen, L.B., and Weinstein, I.B. (1990). Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium. Cancer Res. 50, 677-685.
10. Sweet, S., and Singh, G. (1995). Accumulation of human promyelocytic leukemic (HL-60) cells at two energetic cell cycle checkpoints.Cancer Res. 55 (22), 5164-5167.
11. Weiss, M.J., Wong, J.R., Ha, C.-S., Bleday, R., Salem, R.R., Steele, G.D., and Chen, L.B. (1987). Dequalinium, a topical antimicrobial agent, displays anticarcinoma activiy based on selective mitochondrial accumulation. Proc. Natl. Acad. Sci. USA 84, 5444-5448.
12. Weissig, V., Lasch, J., Erdos, G., Meyer, H.M., Rowe, T.C., and Hughes, J. (1998). DQAsomes: A novel potential drug and gene delivery system made from dequalinium, Pharmaceutical Research. 15 (2), 334-337.
13. Xu, Y., and Szoka, F.C. (1996). Mechanism od DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 35, 5616-5623.